|
|
|
|
|
13.07.26 - 15:42
|
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
|
|
|
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Analytical Bioventures S.C.A (RCS B89265)
23, Val Fleuri, L-1526 Luxembourg
2.
Reason for the notification
a)
Position / status
Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)
Initial notification / amendment
Initial
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Eurofins Scientific S.E.
b)
LEI
52...
|
|
|
13.07.26 - 13:30
|
Sanofi Neutral (DPA-AFX)
|
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Sanofi mit einem Kursziel von 88 Euro auf "Neutral" belassen. Beim Pharmakonzern stehe Optimismus für das Mittel Dupixent Zurückhaltung für Beyfortus gegenüber, schrieb Matthew ......
|
|
|
13.07.26 - 13:24
|
Sartorius Stedim Biotech Neutral (DPA-AFX)
|
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Sartorius Stedim mit einem Kursziel von 220 Euro auf "Neutral" belassen. Beim Laborzulieferer stehe eine mögliche Trendwende beim Auftragseingang für Laborausrüstung und ein ......
|
|
|
13.07.26 - 11:30
|
Abivax-Aktie: Analysten erhöhen Prognosen – diese Woche Übernahmeknall? (Sharedeals)
|
|
|
Die Abivax-Aktie bleibt einer der spannendsten Biotech-Werte des Jahres. Nachdem Reuters zuletzt bestätigt hatte, dass der französische Wirkstoffentwickler mit mehreren Interessenten über eine mögliche Übernahme gesprochen haben soll, hat sich das fundamentale Bild in den vergangenen Tagen weiter aufgehellt. Gleich mehrere Investmentbanken hoben ihre Einschätzungen an oder bestätigten ihre positiven Bewertungen – ein wichtiges Signal […]
The post Abivax-Aktie: Analysten erhöhen Prognosen – diese Woche Übernahmeknall? first appeared on sharedeals.de....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.07.26 - 08:06
|
ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL (Business Wire)
|
|
|
WOIPPY, France--(BUSINESS WIRE)--Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party.
The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1125268.
With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees).
About ABL Diagnostics (ABLD)
ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers:
Molecular ...
|
|
|
09.07.26 - 22:24
|
Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants (GlobeNewswire EN)
|
|
|
Daix (France), New York City (New York, United States), July 9, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), is pleased to announce the completion of the final step of the transactions previously announced on June 2, 2026 (the “Combined Transaction”) through the issuance of approximately 15.7 million new warrants (bons de souscription d'actions) (the "New EIB Warrants") to the European Investment Bank (the "EIB") and the surrender and cancellation of all remaining warrants originally issued to the EIB in January 2024 (the “Legacy EIB Tranche B Warrants”) that were not repurchased in the Combined Transaction....
|
|
|
|
|
|
|
09.07.26 - 16:09
|
Virbac Reaches $500K in Donations for U.S. Animal Charities (PR Newswire)
|
|
|
Every Pet Project donation program continues to strengthen the ecosystem of care for pets in need WESTLAKE, Texas, July 9, 2026 /PRNewswire/ -- Virbac announced that its Every Pet Project donation program has reached $500,000 in cumulative donations to animal charities nationwide. Since......
|
|
|
|
|
|
|
08.07.26 - 18:03
|
SpineGuard Announces its H1 2026 Revenue (Business Wire)
|
|
|
PARIS & BOULDER, Colo.--(BUSINESS WIRE)--Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.
In the United States, the transitional effects related to the sale of SpineGuard Inc. and the shift to a distribution model were anticipated. These effects are accompanied by an improvement in our profitability per unit sold and should enable a gradual ramp-up in sales volumes of Pediguard devices thanks to commercial synergies with Omnia Medical. Pr...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
